Shopless says 3.2% unemployment isn’t the whole story for the NZ Job Market
WELLINGTON, New Zealand, June 23, 2022 /PRNewswire/ -- As government statistics show the unemployment rate remains around 3.2%, employers are in the media saying they can't find employees, while employees take to social media to decry the lack of jobs or conflicts caused by mandates. Yet, Shopless is reporting continual increases in the number of vacancies advertised, so has set...
ESPGHAN Annual Meeting 2022: Nordic lower-protein diet could hold key to instilling healthier eating habits in babies, new study finds
COPENHAGEN, Denmark, June 23, 2022 /PRNewswire/ -- Starting babies and toddlers on a lower protein Nordic-style diet with a greater focus on plant-based food may be the key to healthier eating habits, according to new research being presented today at the 54th Annual Meeting of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). Babies fed taster portions...
China Pharma Announces Receipt of Noncompliance Notice from NYSE American
HAIKOU, China, June 23, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on June 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the "Exchange") stating that the Company was not in compliance with the continued listing standards...
First American Patient Treated with VenusP-Valve™ Under Compassionate Use
HANGZHOU, China, June 22, 2022 /PRNewswire/ -- VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), recently completed its first compassionate use at University of Virginia Advanced Cardiac Valve Center in the U.S. The procedure was performed at the Center by Professor Scott Lim's team...
2022 Tang Prize Laureates–Six Voices that Provide Stability to the World
TAIPEI, June 22, 2022 /PRNewswire/ -- Since the outbreak of COVID-19, more than 530 million inflections have been reported globally. With the virus still raging in many countries, the world is suffering from supply chain disruptions and decade-high inflation, which has been exacerbated by the rising food and fuel prices due to regional conflicts. Political tensions in the international...
Sirnaomics to Present the Latest Developments of Dual-Targeted RNAi Therapeutics based on its Proprietary GalAhead™ Program at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium
GAITHERSBURG, Md. and SUZHOU, China, June 22, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company's Chief Technology Officer, Dmitry Samarsky, PhD, will present the latest developments and expanded applications of its Dual-Targeted RNAi therapeutics based on its proprietary GalAhead™ technology...
Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence
HONG KONG, June 21, 2022 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce its collaboration with Dr. Nancy Etcoff of Harvard Medical School. Dr. Etcoff is widely recognized...
Scientists take the first step to master an all-powerful cell type in the beginning of life
Sheng Ding and his team at Tsinghua University School of Pharmaceutical Sciences publish innovative work in Nature BEIJING, June 21, 2022 /PRNewswire/ -- From cloning to regeneration, how to find alternative paths to create or rejuvenate life has been one of the big questions for biologists. It is this question that's behind the work of generations of scientists who...
JNCCN: Mismatch in Breast Cancer Trial Results and Real-World Outcomes Based on Treatment Discontinuation
New population study on adjuvant hormone therapy for breast cancer finds correlation between hot flashes and poorer outcomes—in contrast to clinical trial results; likely due to patients with side-effects ending treatment early. PLYMOUTH MEETING, Pa., June 21, 2022 /PRNewswire/ -- New research in the June 2022 issue of JNCCN—Journal of the National Comprehensive...
Zeus Invests in Global Expansion Program to Increase Catheter Manufacturing Capacity
ORANGEBURG, S.C., June 21, 2022 /PRNewswire/ -- Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide. The first phase of the expansion program is already underway at the company's San Jose location in California. This initial project will significantly...
